PTPN11 and non-small cell lung carcinoma: Supportive of our hypothesis is recently published data by Chen and colleagues showed in a NSCLC model system that combined SHP2 and PD-L1 inhibition, with accompanying radiation, can overcome resistance to PD-1 inhibitors [11].